ACM	Acetaminophen
ALP	Alkaline phosphatase
ALT	Alanine aminotransferase
AMD	Amiodarone
AMP	Amineptine
AOPs	Adverse outcome pathways
CoA	Coenzyme A
CPT	Carnitine palmitoyl-transferase
DDN	Didanosine
DIFLD	Drug-induced fatty liver disease
DISH	Drug-induced steatohepatitis
DNL	De novo lipogenesis
DXC	Doxycycline
FA	Fatty acid
FAO	Fatty acid β-oxidation
FLR	Fialuridine
FLU	Fluorouracil
GLC	Glucocorticoids
IBU	Ibuprofen
IRI	Irinotecan
MASH	Metabolic dysfunction-associated steatohepatitis
MASLD	Metabolic dysfunction-associated steatotic liver disease
MetALD	Metabolic alcohol-related liver disease
MPT	Mitochondrial permeability transition
MRC	Mitochondrial respiratory chain
mtDNA	Mitochondrial DNA
MTP	Microsomal triglyceride transfer protein
MTX	Methotrexate
NAP	Naproxen
NR	Nuclear receptor
NRTIs	Nucleoside reverse transcriptase inhibitors
NSAIDs	Nonsteroidal anti-inflammatory drugs
OXPHOS	Oxidative phosphorylation
PER	Perhexiline
PIR	Pirprofen
ROS	Reactive oxygen species
SA	Salicylic
SLD	Steatotic liver disease
STV	Stavudine
TET	Tetracycline
TF	Transcription factors
TG	Triglyceride
TGL	Troglitazone
TMF	Tamoxifen
TNP	Tianeptine
VLDL	Very low-density lipoprotein
VPA	Valproic
ZDV	Zidovudine
ΔΨm	Mitochondrial transmembrane potential